Withdrawn from the Canadian, US, and UK markets in 1963 due to concerns involving neutropenia.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Norepinephrine | The therapeutic efficacy of Norepinephrine can be increased when used in combination with Thenalidine. |
| Epinephrine | The therapeutic efficacy of Epinephrine can be increased when used in combination with Thenalidine. |
| Droxidopa | The therapeutic efficacy of Droxidopa can be increased when used in combination with Thenalidine. |
| Levonordefrin | The therapeutic efficacy of Levonordefrin can be increased when used in combination with Thenalidine. |
| Protokylol | The therapeutic efficacy of Protokylol can be increased when used in combination with Thenalidine. |
| Racepinephrine | The therapeutic efficacy of Racepinephrine can be increased when used in combination with Thenalidine. |
| Theodrenaline | The therapeutic efficacy of Theodrenaline can be increased when used in combination with Thenalidine. |
| Deoxyepinephrine | The therapeutic efficacy of Deoxyepinephrine can be increased when used in combination with Thenalidine. |
| Ephedrine | The therapeutic efficacy of Ephedrine can be increased when used in combination with Thenalidine. |